Side Effects in Older Adults | Blocking Immune Cells | Medulloblastoma, Cancer Information Highlights, 12/22/2021

National Cancer Institute sent this bulletin at 12/22/2021 01:10 PM EST
National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share
Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
 
New from NCI
Reducing Side Effects from Cancer Treatment for Older Adults
older person's hand holding pills   Results from a clinical trial show that a tool that measures many aspects of an older person’s health, ability to function, and social support can help guide cancer treatment and reduce side effects.
Test Detects Early Signs of Remaining Cancer in Kids Treated for Medulloblastoma
MRI of brain tumor   A new test could be used to tell which children treated for medulloblastoma have a high risk of their cancer returning. The test finds DNA shed into cerebrospinal fluid from remaining tumor cells.
Immunotherapy Combo Better as First Treatment for Certain Melanomas

Read about a clinical trial that shows that ipilimumab (Yervoy) and nivolumab (Opdivo) given together is better than a combo of the targeted therapies dabrafenib (Tafinlar) and trametinib (Mekinist) as the first treatment for metastatic BRAF-positive melanoma.
Nothing Will Stop Us from Ending Cancer as We Know It
NCA 50 Logo   As we mark the 50th anniversary of the signing of the National Cancer Act of 1971 on December 23, we encourage you to revisit stories featured throughout the year from across the cancer community.
Video: Nothing Will Stop Us

In the 50 years since the signing of the National Cancer Act, our understanding of cancer has grown and we’ve made great strides in preventing, finding, and treating it. But there's more work to do. This video describes efforts to continue to make progress against cancer.
Tumors May Shed Protein to Create Barriers that Block Immune Cells

Cancer cells can shed a protein called DDR1 that helps create dense barriers around some breast tumors. A study in mice showed that these barriers can prevent immune cells from entering and killing tumors.
 
Also of Interest
Asbestos Exposure and Cancer Risk

Asbestos is a substance that occurs in nature and has been used in many industries. Learn more about the health hazards it causes and who to contact for more information.
Cancer Currents Blog Screening and Early Detection Collection

This page features a collection of Cancer Currents blog posts about research on screening for cancer and finding it early. Read news stories about the impact of screening, new technologies, and ways to improve the safety and usefulness of screening.
Contact Us for Help

Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.